The integration of genomics into the field of oncology has ushered in a transformative era in cancer care, enhancing both diagnosis and prognosis by allowing clinicians to understand the genetic basis of cancers more deeply. This shift towards a genomics-driven approach enables more precise and targeted treatment strategies, fundamentally altering the oncology landscape.
This blog post explores how genomics is revolutionizing cancer diagnosis and prognosis, and how specific features of EDC systems, both existing and potential, support this vital work.
Read full article here:
Other Guides
-
Read more +Captivate™ EDC vs. Paper Data Collection
Time, Efficiency, and Cost | Is Paper Less Expensive than EDC?
Historically, a common barrier to entry for implementing Electronic Data Capture (EDC) systems for small studies is the
upfront costs, a large part of which, comes from professional services fees. Luckily, as technology has evolved, there has
been an industry-wide shift away from legacy EDC systems, which require p... -
Read more +Crossing the Final Frontier: Space Medicine and Digital Health
Space exploration has always pushed the boundaries of human knowledge and technology, and as we venture further into the cosmos, the health and well-being of astronauts remain paramount. The unique challenges of the space environment—microgravity, radiation, isolation—demand innovative solutions for medical monitoring and care. Enter the realm of digital health technologies, which have beco...
-
Read more +
Liquid Biopsy: The Future of Non-Invasive Cancer Diagnostics
Liquid biopsy is an innovative and increasingly influential method in cancer diagnostics, offering significant advantages over traditional tissue biopsy by detecting cancer information through a simple blood sample. This non-invasive technique allows for the detection of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other cancer-related biomarkers in the bloodstream. In thi...